Immunogen reported $44.32M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Acceleron Pharma XLRN:US $ 91.6M 3.24M
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Amgen AMGN:US $ 5.7B 1.93B
Arena Pharmaceuticals ARNA:US $ 144.39M 12.4M
Astellas Pharma 4503:JP 290.05B 41.99B
AstraZeneca AZN:LN 7.09B 1.67B
Bluebird Bio BLUE:US $ 248.31M 4.31M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Cerulean Pharma CERU:US $ 9.16M 1.84M
Dicerna Pharmaceuticals DRNA:US $ 81.58M 4.87M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Emergent Biosolutions EBS:US $ 383M 135.4M
Exelixis EXEL:US $ 262.17M 12.67M
Halozyme Therapeutics HALO:US $ 43.41M 15.84M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Immunogen IMGN:US $ 44.32M 305K
Intrexon XON:US $ 49.25M 7.06M
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Macrogenics MGNX:US $ 71.04M 2.86M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Novartis NVS:US 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Seattle Genetics SGEN:US $ 478.08M 23.68M